Related Experiment Video
Updated: Jun 3, 2025
06:28
E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
8.2K
Validation of a Cancer-Focused Information Seeking Experience (ISEE) Scale
Ashley B Murray1, Neha Trivedi2, Roxanne E Jensen3
1Behavioral Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, Maryland, USA.
Journal of Health Communication
|January 10, 2025
Summary
The Information Seeking Experience (ISEE) scale reliably and validly measures cancer information-seeking behaviors. This tool can track health information needs in the population to improve cancer information accessibility.
Area of Science:
- Health Communication
- Psychometrics
- Cancer Control
Background:
- Health information seeking is crucial for health maintenance and disease risk reduction, particularly for cancer.
- Challenges in accessing and comprehending health information necessitate accurate measurement of health information-seeking behaviors.
- Prior research on the Information Seeking Experience (ISEE) scale requires further validation.
Purpose of the Study:
- To formally evaluate the validity and reliability of the four-item, cancer-focused Information Seeking Experience (ISEE) scale.
- To assess the psychometric properties of the ISEE scale in a nationally representative sample of U.S. adults.
- To establish the ISEE scale as a dependable tool for measuring cancer information-seeking experiences.
Main Methods:
- A cross-sectional, nationally representative health survey of U.S. adults was conducted.
- The four-item, cancer-focused Information Seeking Experience (ISEE) scale was administered.
- Statistical analyses included assessments of normality, internal consistency, unidimensionality, construct validity, and discriminant validity.
Main Results:
- The ISEE scale items demonstrated acceptable normality, medium to strong correlations, and strong internal consistency (Cronbach's α = .85).
- Confirmatory factor analysis supported a unidimensional structure (CFI = .997, TLI = .992, SRMR = .012).
- The scale exhibited construct validity with sociodemographic characteristics and discriminant validity with measures of depression, anxiety, communication, and social support.
Conclusions:
- The four-item, cancer-focused ISEE scale is a reliable and valid measure of cancer information-seeking experiences.
- The ISEE scale can be utilized in future population surveys to monitor information support needs related to health and cancer.
- Findings support the use of the ISEE scale to inform efforts ensuring accessible and understandable cancer information.
Related Concept Videos
01:21Cancer Survival Analysis
328
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
328
02:49Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K